Omeros (OMER) Announces FDA Grants Orphan Drug Designation for OMS721 for Treatment of IgA Nephropathy
Tweet Send to a Friend
Omeros Corporation (NASDAQ: OMER) today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
